Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 696

Results For "US"

8054 News Found

Hekka Labs introduces decentralized chronic disease data management in South Asia
Digitisation | January 14, 2022

Hekka Labs introduces decentralized chronic disease data management in South Asia

Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase


AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons
Medical Device | January 13, 2022

AliveCor’ KardiaMobile gets NICE approval to detect irregular heart rhythm symptons

KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales


South Korea approves Novavax Covid-19 vaccine
Drug Approval | January 13, 2022

South Korea approves Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea


Metropolis Healthcare opens MedEngage Scholarship programme
News | January 13, 2022

Metropolis Healthcare opens MedEngage Scholarship programme

The last date to apply for this program is 18th January 2022


Normalised quarter with impending margin pressure: ICICI Direct
News | January 13, 2022

Normalised quarter with impending margin pressure: ICICI Direct

ICICI Direct gives a preview on the earnings narrative for Q3FY22


BioGenex RT-PCR Kit detects all Covid variants in half the time
Medical Device | January 13, 2022

BioGenex RT-PCR Kit detects all Covid variants in half the time

This test analyses samples in VTM directly without the need for RNA extraction step


AstraZeneca studies show its booster effective against all variants
News | January 13, 2022

AstraZeneca studies show its booster effective against all variants

New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria


Novel preventive vaccine for Parkinson’s move into human trials
Biotech | January 12, 2022

Novel preventive vaccine for Parkinson’s move into human trials

MultiTEP Platform-based vaccine targeting three B cell epitopes of pathological ?-Synuclein simultaneously shows protective efficacy in mouse model of synucleinopathies


Veristat supported marketing applications for 12 % of all FDA Novel Drug Approvals in 2021
News | January 12, 2022

Veristat supported marketing applications for 12 % of all FDA Novel Drug Approvals in 2021

This surpasses the number of approvals supported in 2020


Amgen and Arrakis collaborate for small molecule therapeutics
Biotech | January 12, 2022

Amgen and Arrakis collaborate for small molecule therapeutics

Under the terms of the agreement, Arrakis will lead research activities for the identification of RNA-targeted small molecule (rSM) binders against a broad set of targets nominated by Amgen